Dr. Orellana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 DNA Way
South San Francisco, CA 94080
Education & Training
Emory UniversityMSc, Clinical Research, 2020 - 2022
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Brown UniversityResidency, Internal Medicine, 2014 - 2017
Geisel School of Medicine at DartmouthClass of 2014, MD
Certifications & Licensure
GA State Medical License 2020 - 2024
VA State Medical License 2017 - 2020
RI State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsGlofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, random...Jeremy S Abramson, Matthew Ku, Mark Hertzberg, Hui-Qiang Huang, Christopher P Fox
Lancet. 2024-11-16 - TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.Max J Gordon, David A Bond, Adam S Kittai, Neda Amirmokhtari, Abigail Steinbrunner
Haematologica. 2023-11-01 - 7 citationsLow neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.Andres Chang, Jean L Koff, Lilin Lai, Victor M Orellana-Noia, Minal Surati
Blood Advances. 2023-06-13
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Victor M. Orellana-Noia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...Victor M. Orellana-Noia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
